Hasty Briefsbeta

Bilingual

Serum Neurofilament Light Chain and Cardiovascular Outcomes in Patients With Atrial Fibrillation - PubMed

5 hours ago
  • #Atrial Fibrillation
  • #Cardiovascular Risk
  • #Biomarker
  • Elevated serum neurofilament light chain (sNfL) levels are associated with increased risk of major vascular events in atrial fibrillation patients.
  • Higher sNfL concentrations correlate with nonfatal stroke, cardiovascular death, heart failure hospitalization, and all-cause mortality.
  • No significant association was found between sNfL levels and myocardial infarction risk.
  • Study suggests sNfL as a potential biomarker for cardiovascular risk assessment in atrial fibrillation patients.